Abstract
In the last few decades, obesity has captured the attention of the medical community, as well as the general public. Obesity has been shown to be a direct cause or a contributor to the development of various chronic diseases. In contrast, higher weight has been linked to better outcomes in patients with chronic obstructive pulmonary disease (COPD). It also has been recognized that “not all weight has been created equal” and its not the absolute weight in kilograms or the body-mass index (BMI), but rather the fat-free mass index (FFMI) that is a better measure of the nutritional status and the overall prognosis in COPD patients. While the impact of the weight and the nutritional status on the lung cancer outcomes has been similar to that of COPD, the relationship between the obesity and asthma has been more complex and multi-faceted. The article will offer a concise, rather than a comprehensive review of such relationships between the nutritional status and the natural history of three chronic lung diseases. The effects of nutritional supplements, alternative medications, and other interventions will be discussed in the context of the individual diseases (COPD, asthma and lung cancer).
Keywords: Obesity, COPD, asthma, lung cancer, body mass index, fat free mass index
Current Respiratory Medicine Reviews
Title: Obesity in the Patient with Lung Disease
Volume: 4 Issue: 2
Author(s): Zaza I. Cohen
Affiliation:
Keywords: Obesity, COPD, asthma, lung cancer, body mass index, fat free mass index
Abstract: In the last few decades, obesity has captured the attention of the medical community, as well as the general public. Obesity has been shown to be a direct cause or a contributor to the development of various chronic diseases. In contrast, higher weight has been linked to better outcomes in patients with chronic obstructive pulmonary disease (COPD). It also has been recognized that “not all weight has been created equal” and its not the absolute weight in kilograms or the body-mass index (BMI), but rather the fat-free mass index (FFMI) that is a better measure of the nutritional status and the overall prognosis in COPD patients. While the impact of the weight and the nutritional status on the lung cancer outcomes has been similar to that of COPD, the relationship between the obesity and asthma has been more complex and multi-faceted. The article will offer a concise, rather than a comprehensive review of such relationships between the nutritional status and the natural history of three chronic lung diseases. The effects of nutritional supplements, alternative medications, and other interventions will be discussed in the context of the individual diseases (COPD, asthma and lung cancer).
Export Options
About this article
Cite this article as:
Cohen I. Zaza, Obesity in the Patient with Lung Disease, Current Respiratory Medicine Reviews 2008; 4 (2) . https://dx.doi.org/10.2174/157339808784222803
DOI https://dx.doi.org/10.2174/157339808784222803 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cytogenetic and Molecular Abnormalities in Myelodysplastic Syndrome
Current Molecular Medicine Preventive and Therapeutic Effects of the Retinoid X Receptor Agonist Bexarotene on Tumors
Current Drug Metabolism Biological and Clinical Significance of Polymorphisms in NAD(P)H: Quinone Oxidoreductase 1 (NQO1)
Current Pharmacogenomics The Potential Anti-Tumorigenic and Anti-Metastatic Side of the Proprotein Convertases Inhibitors
Recent Patents on Anti-Cancer Drug Discovery Nilotinib Therapy in Chronic Myelogenous Leukemia: The Strength of High Selectivity on BCR/ABL
Current Drug Targets The Diterpenoids of the Genus Elaeoselinum (Apiaceae) and their Biological Properties
Current Organic Chemistry ChemoImmunoModulation: Immune Regulation by the Antineoplastic Chemotherapeutic Agents
Current Medicinal Chemistry Graphical Abstracts
Letters in Drug Design & Discovery Acyclonucleosides, Modified Seco-Nucleosides, and Salicyl- or Catechol- Derived Acyclic 5-Fluorouracil O,N-Acetals: Antiproliferative Activities, Cellular Differentiation and Apoptosis
Current Medicinal Chemistry IP6 & Inositol in Cancer Prevention and Therapy
Current Cancer Therapy Reviews Depsipeptides from Microorganisms: A New Class of Antimalarials
Mini-Reviews in Medicinal Chemistry Ovarian Cancer Biomarkers: Headway Towards Early Diagnosis
Current Chemical Biology Skeletal Muscle in Cancer Cachexia: The Ideal Target of Drug Therapy
Current Cancer Drug Targets On The Edge of Validation – Cancer Protease Fibroblast Activation Protein
Mini-Reviews in Medicinal Chemistry Clinical Importance of Assessment of Type 2 Diabetes Mellitus with Visceral Obesity. A Japanese Perspective
Current Diabetes Reviews NK-1 Receptor Antagonists: A New Paradigm in Pharmacological Therapy
Current Medicinal Chemistry Advances in the Development of Bradykinin Receptor Ligands
Current Topics in Medicinal Chemistry Editorial [Hot topic:Utilizing Chinese Medicines to Improve Cancer Therapy - Fiction or Reality?(Guest Editors: Ying Huang and Moses Sing Sum Chow)]
Current Drug Discovery Technologies A peptide microarray fabricated on a non-fouling phosphatidylcholine-polymer-coated surface for a high-fidelity analysis of a cellular kinome
Current Medicinal Chemistry Peptides for In Vivo Target-Specific Cancer Imaging
Mini-Reviews in Medicinal Chemistry